✦ LIBER ✦

Sa1499 Duloxetine for the Treatment of Patients With Suspected Sphincter of Oddi Dysfunction: An Open-Label Pilot Study

✍ Scribed by Qi Wu; Peter B. Cotton; Valerie Durkalski; Christopher Lawrence; Rebekah Whichard; Olga Brawman-Mintzer

Book ID: 119250581
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 64 KB
Volume: 73
Category: Article
ISSN: 1097-6779
DOI: 10.1016/j.gie.2011.03.233

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Duloxetine in the treatment of irritable

Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study

✍ Brian P. Brennan; Kate V. Fogarty; Jacqueline L. Roberts; Karina A. Reynolds; Ha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Abstract ## Objective To assess the efficacy of duloxetine for irritable bowel syndrome (IBS). ## Methods We conducted an open‐label 12‐week trial of duloxetine 60 mg daily in 15 patients with IBS without concurrent major depressive disorder. The primary outcome measure was average abdominal

Duloxetine in the treatment of adolescen

Duloxetine in the treatment of adolescents with attention deficit/hyperactivity disorder: an open-label study

✍ Javad Mahmoudi-Gharaei; Nasrin Dodangi; Mehdi Tehrani-Doost; Toktam Faghihi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

Objective The main aim of this study was to explore the efficacy and safety of duloxetine, a serotonin and norepinephrine reuptake inhibitor, in the treatment of adolescents with attention deficit/hyperactivity disorder (ADHD). Methods Seventeen adolescents aged 11-18 years, diagnosed with ADHD, par

Atomoxetine for the treatment of executi

Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open-label study

✍ Laura Marsh; Kevin Biglan; Melissa Gerstenhaber; James R. Williams 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB 👁 1 views

## Abstract Executive dysfunction (ED) is a prominent and often disabling feature of cognitive impairment in Parkinson's disease (PD). Few studies have examined treatments. Given the role of noradrenergic pathology in ED, atomoxetine, a norepinephrine reuptake inhibitor indicated for attention defi

Su1680 Post-ERCP Pancreatitis in the EPI

Su1680 Post-ERCP Pancreatitis in the EPISOD Study of Sphincterotomy in Patients With Suspected Sphincter of Oddi Dysfunction. Results and Predictors

✍ Yaghoobi, Mohammad; Durkalski-Mauldin, Valerie; Cotton, Peter B. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 313 KB

Efficacy of rosuvastatin for the treatme

Efficacy of rosuvastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study

✍ Takashi Nakahara; Hideyuki Hyogo; Yuki Kimura; Tomokazu Ishitobi; Koji Arihiro; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Efficacy of pitavastatin for the treatme

Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study

✍ Hideyuki Hyogo; Tadashi Ikegami; Katsutoshi Tokushige; Etsuko Hashimoto; Kazuo I 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB